
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.720 | 1.720 | 0.000 |
Shares | 98.280 | 98.280 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.325 | 32.145 |
Price to Book | 3.023 | 4.504 |
Price to Sales | 3.443 | 5.117 |
Price to Cash Flow | 15.247 | 22.245 |
Dividend Yield | 0.691 | 0.713 |
5 Years Earnings Growth | 16.492 | 15.669 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 90.940 | 96.105 |
Basic Materials | 6.080 | 5.167 |
Financial Services | 2.970 | 1.555 |
Number of long holdings: 45
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.50 | 1,670.00 | -2.83% | |
Dr Reddy’s Laboratories | INE089A01031 | 8.95 | 1,231.30 | +0.74% | |
Cipla | INE059A01026 | 8.85 | 1,482.50 | +0.95% | |
Divi's Labs | INE361B01024 | 6.71 | 6,485.00 | -0.81% | |
Aurobindo Pharma | INE406A01037 | 5.30 | 1,192.00 | +0.32% | |
Lupin | INE326A01037 | 4.73 | 1,968.40 | -0.02% | |
Alkem Laboratories Ltd | INE540L01014 | 4.42 | 5,311.50 | +0.24% | |
Mankind Pharma | INE634S01028 | 3.50 | 2,416.45 | -0.88% | |
Gland | INE068V01023 | 3.39 | 1,537.80 | -0.57% | |
Zydus Lifesciences | INE010B01027 | 3.10 | 902.15 | -0.14% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 649.63B | 2.73 | 18.31 | 14.06 | ||
ICICI Focused Bluechip Eq RetailDiv | 649.63B | 1.98 | 17.47 | 13.25 | ||
ICICI Prud Focused Bluechip Div | 649.63B | 2.68 | 18.74 | 14.55 | ||
ICICI Prud Focused Bluechip Gr | 649.63B | 2.91 | 19.01 | 14.91 | ||
ICICI Balanced Adv Dir Div | 605.91B | 3.59 | 13.20 | 11.58 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review